Navigation Links
Penn study suggests another avenue for detecting Alzheimer's disease
Date:4/1/2011

PHILADELPHIA Researchers at the University of Pennsylvania School of Medicine have determined that a well-known chemical process called acetylation has a previously unrecognized association with one of the biological processes associated with Alzheimer's disease and related disorders. The findings were published in the latest issue of Nature Communications.

Tau is one of the primary disease proteins associated with a suite of neurodegenerative diseases. Tau proteins are expressed primarily in the central nervous system where they help with the assembly and stability of microtubules, protein structures that are the backbone of the nerve-cell communication system.

"Acetylation was only detected in diseased brain tissue from patients with Alzheimer's disease or frontotemporal degeneration, suggesting it may have a role in tau transformation linked to disease onset and progression," says senior author Virginia M.-Y. Lee, PhD, director of Penn's Center for Neurodegenerative Disease Research. "This suggests that one type of acetylation is a potential target for drug discovery and biomarker development for Alzheimer's and related tauopathies."

The researchers demonstrated that tau acetylation led to a loss of one of its major functions - to promote microtubule assembly, in addition to gaining a toxic function, pathological tau aggregation. Mass spectrometry analysis identified specific acetylation sites in the tau protein sequence that overlapped with known microtubule binding sequences, so acetylation may also play a role in faulty binding of tau to microtubules.

How normal tau becomes disengaged from microtubules to form disease-related clumps remains unknown. This study shows that acetylation is most likely another chemical modification implicated in neurodegenerative disorders to be explored as a potential way to detect and fight brain disease.

According to Lee, the next steps to follow up on this discovery are to pursue basic research into the mechanisms underlying this pathological acetylation of tau and its role in neurodegeneration in Alzheimer's disease and related tauopathies. In addition, she noted that "Our highest priority will be to find ways to translate these findings into better diagnostics and therapeutics for patients with Alzheimer's disease or frontotemporal degeneration."


'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. Many Moms Have Kids With Different Dads, U.S. Study Finds
2. Surprising finding from smoke inhalation study
3. Prostate Cancer Screening Doesnt Cut Death Rates: Study
4. New lung cancer staging system (TNM 7) better predicts local/regional recurrence, study shows
5. Soy increases radiations ability to kill lung cancer cells, study shows
6. Moms With Tough Childhoods More Likely to Have Smaller Babies: Study
7. For Young Kids With Pneumonia, Timing of Antibiotic Critical: Study
8. Pilot study examines stress, anxiety and needs of young women with a unique breast cancer
9. Case Western Reserve receives $1.6M to study tumor cells and immune cell detection
10. STUDY: 3 square meals a day paired with lean protein help people feel full during weight loss
11. Antibacterial Soap Additive Accumulates in Fish: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penn study suggests another avenue for detecting Alzheimer's disease
(Date:12/6/2016)... Sacramento, CA (PRWEB) , ... December 06, 2016 , ... ... travel can disrupt daily routines. That means it's also the season when eating healthy, ... those living with diabetes) on schedule is harder to do. , "Shopping trips, ...
(Date:12/6/2016)... ... 06, 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to ... give freedom to people who need help getting around. For some, advancing age has ... period of rehabilitation after an illness or accident. There is a wide variety of ...
(Date:12/5/2016)... ... December 05, 2016 , ... What: Shriners Hospitals for ... North Pole to our patients – using a video monitor and web-enabled camera. Santa ... will transform the Auditorium into a Christmas Wonderland, which is where the video connection ...
(Date:12/5/2016)... ... December 06, 2016 , ... For many years, Andrew ... both thick and thin. The beauty of the Lithuanian language and its ... In this poetry book, Zubinas lyrically explores all aspects of a living, breathing forest ...
(Date:12/5/2016)... Novato, CA (PRWEB) , ... December 05, 2016 ... ... company, has extended its partnership with leading global lifestyle design firm kathy ireland® ... , Worldwise® and kathy ireland® Worldwide entered into an exclusive licensing agreement three ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016  Parallax Health Sciences, ... pleased to announce that its pharmaceutical business, RoxSan Pharmacy, ... clients, allowing coverage in all of the 42 states ... Michael Rashti Pharm . D, Pharmacist ... very exciting for our business. Medicare B spending last ...
(Date:12/5/2016)... , Dec 5, 2016 Research ... Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease ... - Global Forecasts to 2021" report to their offering. ... , , ... USD 730.7 Million in 2021 from USD 574.8 Million in 2016, ...
Breaking Medicine Technology: